HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair.

Abstract
The vast majority of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma (ALK+ALCL) tumors express the characteristic oncogenic fusion protein NPM-ALK, which mediates tumorigenesis by exerting its constitutive tyrosine kinase activity on various substrates. We recently identified MSH2, a protein central to DNA mismatch repair (MMR), as a novel binding partner and phosphorylation substrate of NPM-ALK. Here, using liquid chromatography-mass spectrometry, we report for the first time that MSH2 is phosphorylated by NPM-ALK at a specific residue, tyrosine 238. Using GP293 cells transfected with NPM-ALK, we confirmed that the MSH2(Y238F) mutant is not tyrosine phosphorylated. Furthermore, transfection of MSH2(Y238F) into these cells substantially decreased the tyrosine phosphorylation of endogenous MSH2. Importantly, gene transfection of MSH2(Y238F) abrogated the binding of NPM-ALK with endogenous MSH2, re-established the dimerization of MSH2:MSH6 and restored the sensitivity to DNA mismatch-inducing drugs, indicative of MMR return. Parallel findings were observed in two ALK+ALCL cell lines, Karpas 299 and SUP-M2. In addition, we found that enforced expression of MSH2(Y238F) into ALK+ALCL cells alone was sufficient to induce spontaneous apoptosis. In conclusion, our findings have identified NPM-ALK-induced phosphorylation of MSH2 at Y238 as a crucial event in suppressing MMR. Our studies have provided novel insights into the mechanism by which oncogenic tyrosine kinases disrupt MMR.
AuthorsK M Bone, P Wang, F Wu, C Wu, L Li, J T Bacani, S E Andrew, R Lai
JournalBlood cancer journal (Blood Cancer J) Vol. 5 Pg. e311 (May 15 2015) ISSN: 2044-5385 [Electronic] United States
PMID25978431 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tyrosine
  • p80(NPM-ALK) protein
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Protein-Tyrosine Kinases
  • Receptor Protein-Tyrosine Kinases
  • MSH2 protein, human
  • MutS Homolog 2 Protein
Topics
  • Anaplastic Lymphoma Kinase
  • Blotting, Western
  • Cell Line, Tumor
  • Chromatography, Liquid
  • DNA Mismatch Repair (physiology)
  • Humans
  • Immunoprecipitation
  • Lymphoma, Large-Cell, Anaplastic (metabolism, pathology)
  • Mass Spectrometry
  • MutS Homolog 2 Protein (metabolism)
  • Mutagenesis, Site-Directed
  • Phosphorylation
  • Protein-Tyrosine Kinases (metabolism)
  • Receptor Protein-Tyrosine Kinases (metabolism)
  • Transfection
  • Tyrosine (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: